Are the available apathy measures reliable and valid? A review of the psychometric evidence

Journal of Psychosomatic Research

Volumn 70, Issue 1, 2011, Pages 73-97

  Clarke, Diana E ^a,b   Ko, Jean Y ^b   Kuhl, Emily A ^a   van Reekum, Robert ^c   Salvador, Rocio ^a   Marin, Robert S ^d  

^a AMERICAN PSYCHIATRIC ASSOCIATION   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Amotivational; Apathy; Assessment; Psychometric properties; Reliability; Validity

Indexed keywords

APATHY; APATHY EVALUATION SCALE; DIAGNOSTIC TEST ACCURACY STUDY; FRONTAL SYSTEM BEHAVIOR SCALE; HUMAN; IRRITABILITY APATHY SCALE; NEUROPSYCHIATRIC INVENTORY; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOMETRY; RATING SCALE; RELIABILITY; REVIEW; UNIFIED PARKINSON DISEASE RATING SCALE; VALIDITY;

ADULT; APATHY; EVALUATION STUDIES AS TOPIC; HUMANS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS;

EID: 78650564564     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2010.01.012     Document Type: Review

References (100)

1. van Reekum R, Stuss DT, Ostrander L Apathy: why care?. J Neuropsychiatry Clin Neurosci 2005, 17:7-19.
2. Clarke DE, van Reekum R, Simard M, Streiner DL, Conn D, Cohen T, et al. Apathy in dementia: clinical and sociodemographic correlates. J Neuropsychiatry Clin Neurosci 2008, 20:337-347.
3. Borroni B, Agosti C, Padovani A Behavioral and psychological symptoms in dementia with Lewy-bodies (DLB): frequency and relationship with disease severity and motor impairment. Arch Gerontol Geriatr 2008, 46:101-106.
4. Borroni B, Turla M, Bertasi V, Agosti C, Gilberti N, Padovani A Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes. Arch Gerontol Geriatr 2008, 47:53-61.
5. Dujardin K, Sockeel P, Devos D, Delliaux M, Krystkowiak P, Destee A, et al. Characteristics of apathy in Parkinson's disease. Mov Disord 2007, 22:778-784.
6. Kirsch-Darrow L, Fernandez HH, Marsiske M, Okun, Bowers D Dissociating apathy and depression in Parkinson disease. Neurology 2006, 67:33-38.
7. Diehl-Schmid J, Pohl C, Perneczky R, Forstl H, Kurz A Behavioral disturbances in the course of frontotemporal dementia. Dement Geriatr Cogn Disord 2006, 22:352-357.
8. Srikanth S, Nagaraja AV, Ratnavalli E Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia. J Neurol Sci 2005, 236:43-48.
9. Guilleminault C, Quera-Salva MA, Goldberg MP Pseudo-hypersomnia and pre-sleep behaviour with bilateral paramedian thalamic lesions. Brain 1993, 116:1549-1563.
10. Starkstein SE, Petracca G, Chemerinski E, Kremer J Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry 2001, 158:872-877.
11. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC Subcortical ischaemic vascular dementia. Lancet Neurol 2002, 1:426-436.
12. Moretti R, Torre P, Antonello RM, Cazzato G Behavioral alterations and vascular dementia. Neurologist 2006, 12:43-47.
13. Andersson S, Krogstad JM, Finset A Apathy and depressed mood in acquired brain damage: relationship to lesion localization and psychophysiological reactivity. Psychol Med 1999, 29:447-456.
14. Finset A, Andersson S Coping strategies in patients with acquired brain injury: relationships between coping, apathy, depression and lesion location. Brain Inj 2000, 14:887-905.
15. Diaz-Olavarrieta C, Cummings JL, Velazquez J, Garcia de la CC Neuropsychiatric manifestations of multiple sclerosis. J Neuropsychiatry Clin Neurosci 1999, 11:51-57.
16. Figved N, Klevan G, Myhr KM, Glad S, Nyland H, Larsen JP, et al. Neuropsychiatric symptoms in patients with multiple sclerosis. Acta Psychiatr Scand 2005, 112:463-468.
17. Rubinsztein JS, Rubinsztein DC, Goodburn S, Holland AJ Apathy and hypersomnia are common features of myotonic dystrophy. J Neurol Neurosurg Psychiatry 1998, 64:510-515.
18. Starkstein SE, Jorge R, Mizrahi R, Robinson RG A prospective longitudinal study of apathy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2006, 77:8-11.
19. Castellon SA, Hinkin CH, Wood S, Yarema KT Apathy, depression, and cognitive performance in HIV-1 infection. J Neuropsychiatry Clin Neurosci 1998, 10:320-329.
20. Lavretsky H, Lesser IM, Wohl M, Miller BL, Mehringer CM Clinical and neuroradiologic features associated with chronicity in late-life depression. Am J Geriatr Psychiatry 1999, 7:309-316.
21. Onyike CU, Sheppard JM, Tschanz JT, Norton MC, Green RC, Steinberg M, et al. Epidemiology of apathy in older adults: the Cache County Study. Am J Geriatr Psychiatry 2007, 15:365-375.
22. Turro-Garriga O, Lopez-Pousa S, Vilalta-Franch J, Turon-Estrada A, Pericot-Nierga I, Lozano-Gallego M, et al. [A longitudinal study of apathy in patients with Alzheimer's disease]. Rev Neurol 2009, 48:7-13.
23. Glodzik-Sobanska L, Slowik A, Kieltyka A, Kozub J, Sobiecka B, Urbanik A, et al. Reduced prefrontal N-acetylaspartate in stroke patients with apathy. J Neurol Sci 2005, 238:19-24.
24. Rozzini L, Chilovi BV, Bertoletti E, Conti M, Delrio I, Trabucchi M, et al. Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. Int Psychogeriatr 2008, 20:86-95.
25. Hama S, Yamashita H, Shigenobu M, Watanabe A, Kurisu K, Yamawaki S, et al. Post-stroke affective or apathetic depression and lesion location: left frontal lobe and bilateral basal ganglia. Eur Arch Psychiatry Clin Neurosci 2007, 257:149-152.
26. Hama S, Yamashita H, Shigenobu M, Watanabe A, Hiramoto K, Kurisu K, et al. Depression or apathy and functional recovery after stroke. Int J Geriatr Psychiatry 2007, 22:1046-1051.
27. Landes AM, Sperry SD, Strauss ME Prevalence of apathy, dysphoria, and depression in relation to dementia severity in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 2005, 17:342-349.
28. Tam CW, Lam LC, Lui VW, Chan WC, Chan SS, Chiu HF, et al. Clinical correlates of functional performance in community-dwelling Chinese older persons with mild cognitive impairment. Int Psychogeriatr 2008, 20:1059-1070.
29. Freels S, Cohen D, Eisdorfer C, Paveza G, Gorelick P, Luchins DJ, et al. Functional status and clinical findings in patients with Alzheimer's disease. J Gerontol 1992, 47:M177-M182.
30. Lechowski L, Benoit M, Chassagne P, Vedel I, Tortrat D, Teillet L, et al. Persistent apathy in Alzheimer's disease as an independent factor of rapid functional decline: the REAL longitudinal cohort study. Int J Geriatr Psychiatry 2008, 24:341-346.
31. de Vugt ME, Riedijk SR, Aalten P, Tibben A, Van Swieten JC, Verhey FR Impact of behavioural problems on spousal caregivers: a comparison between Alzheimer's disease and frontotemporal dementia. Dement Geriatr Cogn Disord 2006, 22:35-41.
32. Robert PH, Berr C, Volteau M, Bertogliati C, Benoit M, Mahieux F, et al. Neuropsychological performance in mild cognitive impairment with and without apathy. Dement Geriatr Cogn Disord 2006, 21:192-197.
33. Robert PH, Clairet S, Benoit M, Koutaich J, Bertogliati C, Tible O, et al. The Apathy Inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int J Geriatr Psychiatry 2002, 17:1099-1105.
34. Aalten P, de Vugt ME, Jaspers N, Jolles J, Verhey FR The course of neuropsychiatric symptoms in dementia. Part I: findings from the two-year longitudinal Maasbed study. Int J Geriatr Psychiatry 2005, 20:523-530.
35. Duffy J Apathy and related disroders of diminished motivation. Guide to neuropsychiatric therapeutics 2006, 1-13. Lippincott Williams & Wilkins, Philadelphia. C. Coffey, T. McAllister, J. Silver (Eds.).
36. Marin RS, Fogel BS, Hawkins J, Duffy J, Krupp B Apathy: a treatable syndrome. J Neuropsychiatry Clin Neurosci 1995, 7:23-30.
37. Padala PR, Petty F, Bhatia SC Methylphenidate may treat apathy independent of depression. Ann Pharmacother 2005, 39:1947-1949.
38. Roth RM, Flashman LA, McAllister TW Apathy and its treatment. Curr Treat Options Neurol 2007, 9:363-370.
39. Mega MS, Masterman DM, O'Connor SM, Barclay TR, Cummings JL The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease. Arch Neurol 1999, 56:1388-1393.
40. Rockwood K, Mintzer J, Truyen L, Wessel T, Wilkinson D Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial. J Neurol Neurosurg Psychiatry 2001, 71:589-595.
41. Bodkin JA, Siris SG, Bermanzohn PC, Hennen J, Cole JO Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia. Am J Psychiatry 2005, 162:388-390.
42. Buchanan RW, Ball MP, Weiner E, Kirkpatrick B, Gold JM, McMahon RP, et al. Olanzapine treatment of residual positive and negative symptoms. Am J Psychiatry 2005, 162:124-129.
43. Politis AM, Vozzella S, Mayer LS, Onyike CU, Baker AS, Lyketsos CG A randomized, controlled, clinical trial of activity therapy for apathy in patients with dementia residing in long-term care. Int J Geriatr Psychiatry 2004, 19:1087-1094.
44. Raglio A, Bellelli G, Traficante D, Gianotti M, Ubezio MC, Villani D, et al. Efficacy of music therapy in the treatment of behavioral and psychiatric symptoms of dementia. Alzheimer Dis Assoc Disord 2008, 22:158-162.
45. Marin RS Differential diagnosis and classification of apathy. Am J Psychiatry 1990, 147:22-30.
46. Marin RS, Biedrzycki RC, Firinciogullari S Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 1991, 38:143-162.
47. Marin RS Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 1991, 3:243-254.
48. Stuss D, van Reekum R, Murphy K Apathy states. Neuropsychology of emotion 2000, Oxford University Press. J. Borod (Ed.).
49. Havighurst RJ Personality and patterns of aging. Gerontologist 1968, 8:20-23.
50. Brodaty H, Altendorf A, Withall A, Sachdev P Do people become more apathetic as they grow older? A longitudinal study in healthy individuals. International Psychogeriatrics 2009, First View:1-11.
51. Marin RS, Firinciogullari S, Biedrzycki RC The sources of convergence between measures of apathy and depression. J Affect Disord 1993, 28:117-124.
52. Robert P, Onyike CU, Leentjens AF, Dujardin K, Aalten P, Starkstein S, et al. Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry 2009, 24:98-104.
53. Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992, 4:134-139.
54. Lloyd S, Streiner D, Shannon S Predictive validity of the emergency physician and global job satisfaction instruments. Acad Emerg Med 1998, 5:234-241.
55. Landis JR, Koch GG The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
56. Clarke DE, van Reekum R, Patel J, Simard M, Gomez E, Streiner DL An appraisal of the psychometric properties of the clinician version of the Apathy Evaluation Scale (AES-C). Int J Methods Psychiatr Res 2007, 16:97-110.
57. Clarke DE, van Reekum R, Simard M, Streiner DL, Freedman M, Conn D Apathy in dementia: an examination of the psychometric properties of the apathy evaluation scale. J Neuropsychiatry Clin Neurosci 2007, 19:57-64.
58. Faerden A, Nesvag R, Barrett EA, Agartz I, Finset A, Friis S, et al. Assessing apathy: the use of the Apathy Evaluation Scale in first episode psychosis. Eur Psychiatry 2008, 23:33-39.
59. Sockeel P, Dujardin K, Devos D, Deneve C, Destee A, Defebvre L The Lille Apathy Rating Scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006, 77:579-584.
60. Dujardin K, Sockeel P, Delliaux M, Destee A, Defebvre L The Lille Apathy Rating Scale: validation of a caregiver-based version. Mov Disord 2008, 23:845-849.
61. Resnick B, Zimmerman SI, Magaziner J, Adelman A Use of the Apathy Evaluation Scale as a measure of motivation in elderly people. Rehabil Nurs 1998, 23:141-147.
62. Lueken U, Seidl U, Volker L, Schweiger E, Kruse A, Schroder J Development of a short version of the Apathy Evaluation Scale specifically adapted for demented nursing home residents. Am J Geriatr Psychiatry 2007, 15:376-385.
63. Strauss ME, Sperry SD An informant-based assessment of apathy in Alzheimer disease. Neuropsychiatry Neuropsychol Behav Neurol 2002, 15:176-183.
64. Overall JE, Gorham DR The Brief Psychiatric Rating Scale. Psychol Rep 1962, 10:790-812.
65. Hedlund JL, Vieweg BW The Brief Psychiatric Rating Scale (BPRS): a comprehensive review. J Oper Psychiatry 1980, 11:48-65.
66. Andersen J, Larsen JK, Korner A, Nielsen BM, Schultz V, Behnke K, et al. The Brief Psychiatric Rating Scale:schizophrenia, reliability and validity studies. Nord J Psychiatry 1986, 40:135-138. Ref Type: Generic.
67. Overall JE, Beller SA The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit. J Gerontol 1984, 39:187-193.
68. Bell M, Milstein R, Beam-Goulet J, Lysaker P, Cicchetti D The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. Reliability, comparability, and predictive validity. J Nerv Ment Dis 1992, 180:723-728.
69. Ligon J, Thyer BA Interrater reliability of the Brief Psychiatric Rating Scale used at a community-based inpatient crisis stabilization unit. J Clin Psychol 2000, 56:583-587.
70. Andreasen NC Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry 1982, 39:784-788.
71. McAdams LA, Harris MJ, Heaton SC, Bailey A, Fell R, Jeste DV Validity of specific subscales of the positive and negative symptom scales in older schizophrenia outpatients. Schizophr Res 1997, 27:219-226.
72. Kay SR, Opler LA, Lindenmayer JP Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res 1988, 23:99-110.
73. Kay SR, Opler LA, Lindenmayer JP The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry Suppl 1989, 59-67.
74. Singh MM, Kay SR A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics. Psychopharmacologia 1975, 43:103-113.
75. Kay SR, Fiszbein A, Lindenmayer JP, Opler LA Positive and negative syndromes in schizophrenia as a function of chronicity. Acta Psychiatr Scand 1986, 74:507-518.
76. Kay SR, Fiszbein A, Opler LA The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
77. Hatton C, Haddock G, Taylor JL, Coldwell J, Crossley R, Peckham N The reliability and validity of general psychotic rating scales with people with mild and moderate intellectual disabilities: an empirical investigation. J Intellect Disabil Res 2005, 49(Pt 7):490-500.
78. Kay SR, Fiszbein A, Vital-Herne M, Fuentes LS The Positive and Negative Syndrome Scale-Spanish adaptation. J Nerv Ment Dis 1990, 178:510-517.
79. Starkstein SE, Merello M The Unified Parkinson's Disease Rating Scale: validation study of the mentation, behavior, and mood section. Mov Disord 2007, 22:2156-2161.
80. Pedersen KF, Larsen JP, Aarsland D Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease. Parkinsonism Relat Disord 2008, 14:183-186.
81. Burns A, Folstein S, Brandt J, Folstein M Clinical assessment of irritability, aggression, and apathy in Huntington and Alzheimer disease. J Nerv Ment Dis 1990, 178:20-26.
82. Nunnally JC, Bernstein IH Psychometric theory (3rd edition) 1994, McGraw-Hill, New York.
83. Grace J, Stout JC, Malloy PF Assessing frontal lobe behavioral syndromes with the Frontal Lobe Personality Scale. Assessment 1999, 6:269-284.
84. Grace J, Malloy P Frontal Systems Behavior Scale (FrSBe): Professional Manual. Lutz, FL, Psychological Assessment Resources 2001.
85. Stout JC, Ready RE, Grace J, Malloy PF, Paulsen JS Factor analysis of the frontal systems behavior scale (FrSBe). Assessment 2003, 10:79-85.
86. Velligan DI, Ritch JL, Sui D, DiCocco M, Huntzinger CD Frontal Systems Behavior Scale in schizophrenia: relationships with psychiatric symptomatology, cognition and adaptive function. Psychiatry Res 2002, 113:227-236.
87. Norton LE, Malloy PF, Salloway S The impact of behavioral symptoms on activities of daily living in patients with dementia. Am J Geriatr Psychiatry 2001, 9:41-48.
88. Ready RE, Ott BR, Grace J, Cahn-Weiner DA Apathy and executive dysfunction in mild cognitive impairment and Alzheimer disease. Am J Geriatr Psychiatry 2003, 11:222-228.
89. Cahn-Weiner DA, Grace J, Ott BR, Fernandez HH, Friedman JH Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease. Neuropsychiatry Neuropsychol Behav Neurol 2002, 15:79-87.
90. Kolitz BP, Vanderploeg RD, Curtiss G Development of the Key Behaviors Change Inventory: a traumatic brain injury behavioral outcome assessment instrument. Arch Phys Med Rehabil 2003, 84:277-284.
91. Belanger HG, Brown LM, Crowell TA, Vanderploeg RD, Curtiss G The Key Behaviors Change Inventory and executive functioning in an elderly clinic sample. Clin Neuropsychol 2002, 16:251-257.
92. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994, 44:2308-2314.
93. Cummings JL The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 1997, 48(5 Suppl 6):S10-S16.
94. Choi SH, Na DL, Kwon HM, Yoon SJ, Jeong JH, Ha CK The Korean version of the neuropsychiatric inventory: a scoring tool for neuropsychiatric disturbance in dementia patients. J Korean Med Sci 2000, 15:609-615.
95. Politis, Mayer LS, Passa M, Maillis A, Lyketsos CG Validity and reliability of the newly translated Hellenic Neuropsychiatric Inventory (H-NPI) applied to Greek outpatients with Alzheimer's disease: a study of disturbing behaviors among referrals to a memory clinic. Int J Geriatr Psychiatry 2004, 19:203-208.
96. Zuidema SU, de Jonghe JF, Verhey FR, Koopmans RT Neuropsychiatric symptoms in nursing home patients: factor structure invariance of the Dutch nursing home version of the neuropsychiatric inventory in different stages of dementia. Dement Geriatr Cogn Disord 2007, 24:169-176.
97. Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 2000, 12:233-239.
98. Iverson GL, Hopp GA, DeWolfe K, Solomons K Measuring change in psychiatric symptoms using the Neuropsychiatric Inventory: Nursing Home version. Int J Geriatr Psychiatry 2002, 17:438-443.
99. Camozzato AL, Kochhann R, Simeoni C, Konrath CA, Pedro FA, Carvalho A, et al. Reliability of the Brazilian Portuguese version of the Neuropsychiatric Inventory (NPI) for patients with Alzheimer's disease and their caregivers. Int Psychogeriatr 2008, 20:383-393.
100. Leung VP, Lam LC, Chiu HF, Cummings JL, Chen QL Validation study of the Chinese version of the neuropsychiatric inventory (CNPI). Int J Geriatr Psychiatry 2001, 16:789-793.